Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | CA1 | P00915 | 3/20 | 0.74 |
| ▸ | CA2 | P00918 | 3/20 | 0.74 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.73 |
| ▸ | MAPT | P10636 | 6/20 | 0.73 |
| ▸ | POLB | P06746 | 1/20 | 0.68 |
| ▸ | HTT | P42858 | 1/20 | 0.68 |
| ▸ | MEN1 | O00255 | 3/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | HPGD | P15428 | 2/20 | 0.64 |
| ▸ | THRB | P10828 | 1/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9070 | 0.89 | ALDH1A1 (0.80) | ALDH1A1CYP1A2CYP2C9CYP2C19CA1 | |
| SCHEMBL5989742 | 0.88 | ALDH1A1 (0.79) | ALDH1A1CYP1A2CYP2C9CYP2C19CA1 | |
| SCHEMBL29768227 | 0.86 | ALDH1A1 (0.76) | ALDH1A1CYP1A2CYP2C9CYP2C19CA1 | |
| SCHEMBL28566115 | 0.86 | ALDH1A1 (0.76) | ALDH1A1CYP1A2CYP2C9CYP2C19CA1 | |
| SCHEMBL11553727 | 0.85 | KDM4E (0.76) | ALDH1A1CYP1A2CYP2C9CYP2C19CA1 | |
| SCHEMBL7155818 | 0.85 | ALDH1A1 (0.74) | ALDH1A1CYP1A2CYP2C9CYP2C19CA1 | |
| SCHEMBL4683758 | 0.84 | KDM4E (1.00) | ALDH1A1CYP1A2CYP2C9CYP2C19CA1 | |
| SCHEMBL11560756 | 0.83 | ALDH1A1 (0.71) | ALDH1A1CYP1A2CYP2C9CYP2C19CA1 | |
| SCHEMBL11550484 | 0.83 | ALDH1A1 (0.71) | ALDH1A1CYP1A2CYP2C9CYP2C19CA1 | |
| SCHEMBL11550481 | 0.83 | KDM4E (0.72) | ALDH1A1CYP1A2CYP2C9CYP2C19CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101591324-B | Three crystal forms of 5-methyl-7-methoxyisoflavone, preparation method thereof, pharmaceutical composition thereof and application thereof | INST MATERIA MEDICA CAMS | 2013-07-10 | — | — | CN | claimed |
| CN-103030619-A | C-crystal-form 5-methyl-7-methoxyiso-flavone and preparation method, pharmaceutical compositions and application of C-crystal-form 5-methyl-7-methoxyiso-flavone | INST MATERIA MEDICA CAMS | 2013-04-10 | — | — | CN | claimed |
| CN-101591324-A | Three crystal forms of 5-methyl-7-methoxyisoflavone, preparation method thereof, pharmaceutical composition thereof and application thereof | INST MATERIA MEDICA CAMS (CN) | 2009-12-02 | — | — | CN | claimed |
| CN-122067647-A | Prediction and depth verification integration method for traditional Chinese medicine compound action mechanism research | 国药集团德众（佛山）药业有限公司 | 2026-05-19 | — | — | CN | disclosed |
| US-20260128372-A1 | NON-AQUEOUS ELECTROLYTE FOR LITHIUM SECONDARY BATTERY, AND LITHIUM SECONDARY BATTERY COMPRISING SAME | LG CHEMICAL LTD (KR) | 2026-05-07 | — | — | US | disclosed |
| US-20260091067-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MARVELBIOME INC (US) | 2026-04-02 | — | — | US | disclosed |
| EP-4587116-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2025-07-23 | — | — | EP | disclosed |
| EP-4576305-A1 | NON-AQUEOUS ELECTROLYTE FOR LITHIUM SECONDARY BATTERY, AND LITHIUM SECONDARY BATTERY COMPRISING SAME | LG CHEM, LTD. (KR) | 2025-06-25 | — | — | EP | disclosed |
| CN-120153509-A | Nonaqueous electrolyte for lithium secondary battery and lithium secondary battery comprising same | 株式会社LG化学 | 2025-06-13 | — | — | CN | disclosed |
| CN-119619329-A | Detection method of angelica sinensis beverage composition | 广东一方制药有限公司 | 2025-03-14 | — | — | CN | disclosed |
| WO-2025054048-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING LIPID AND CHOLESTEROL METABOLISM ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | MarvelBiome, Inc. (US) | 2025-03-13 | — | — | WO | disclosed |
| CN-103030619-A | C-crystal-form 5-methyl-7-methoxyiso-flavone and preparation method, pharmaceutical compositions and application of C-crystal-form 5-methyl-7-methoxyiso-flavone | INST MATERIA MEDICA CAMS | 2013-04-10 | — | — | CN | disclosed |
| WO-2012120099-A2 | SMALL MOLECULE MODULATORS OF THE COLD AND MENTHOL RECEPTOR TRPM8 | B.R.A.I.N. BIOTECHNOLOGY RESEARCH AND INFORMATION NETWORK AG (DE) | 2012-09-13 | — | — | WO | disclosed |
| WO-2012120099-A2 | SMALL MOLECULE MODULATORS OF THE COLD AND MENTHOL RECEPTOR TRPM8 | B.R.A.I.N. BIOTECHNOLOGY RESEARCH AND INFORMATION NETWORK AG (DE) | 2012-09-13 | — | — | WO | disclosed |
| EP-2497458-A1 | Small molecule modulators of the cold and menthol receptor TRPM8 | B.R.A.I.N. Biotechnology Research And Information Network AG (DE) | 2012-09-12 | — | — | EP | disclosed |
| EP-2497458-A1 | Small molecule modulators of the cold and menthol receptor TRPM8 | B.R.A.I.N. Biotechnology Research And Information Network AG (DE) | 2012-09-12 | — | — | EP | disclosed |
| US-20100028469-A1 | Extracts of Cranberry and Methods of Using Thereof | HERBALSCIENCE GROUP, LLC (US) | 2010-02-04 | — | — | US | disclosed |
| CN-101591324-A | Three crystal forms of 5-methyl-7-methoxyisoflavone, preparation method thereof, pharmaceutical composition thereof and application thereof | INST MATERIA MEDICA CAMS (CN) | 2009-12-02 | — | — | CN | disclosed |
| EP-0710234-A1 | ISOFLAVONE DERIVATIVES | CHINOIN LTD. (HU) | 1996-05-08 | — | — | EP | disclosed |
| WO-1995003293-A1 | ISOFLAVONE DERIVATIVES | CHINOIN LTD. (HU) | 1995-02-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260128372-A1 | NON-AQUEOUS ELECTROLYTE FOR LITHIUM SECONDARY BATTERY, AND LITHIUM SECONDARY BATTERY COMPRISING SAME | CLCN2, CLIC1, RER1 | ALDH1A1 721/4885CYP1A2 2043/4885CYP2C9 1253/4885 |
| US-20260091067-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | IAPP, GPR119, FAHD1 | ALDH1A1 1370/4885CYP1A2 862/4885CYP2C9 1686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.